Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMILAR: Inflectra vs Remicade in IBD Remission
NCT02452151Phase 4Unknown
- Sponsor
- OLVG
- Start
- Aug 2015
- Primary completion
- Aug 2016
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of infliximab in ulcerative colitis (UC), Crohn's disease, sponsored by OLVG. Status: unknown.
02
Drugs
infliximab
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT02452151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452151.